Button, Berry
Croessmann, Sarah
Chu, David
Rosen, D. Marc
Zabransky, Daniel J.
Dalton, W. Brian
Cravero, Karen
Kyker-Snowman, Kelly
Waters, Ian
Karthikeyan, Swathi
Christenson, Eric S.
Donaldson, Josh
Hunter, Tasha
Dennison, Lauren
Ramin, Cody
May, Betty
Roden, Richard
Petry, Dana
Armstrong, Deborah K.
Visvanathan, Kala
Park, Ben Ho http://orcid.org/0000-0001-8119-2291
Funding for this research was provided by:
Susan G. Komen (SAC170079)
National Cancer Institute (CA214494, CA088843, CA194024, CA009314, CA009071)
National Institutes of Health (GM008752)
Commonwealth of Virginia
Article History
Received: 30 November 2018
Accepted: 5 December 2018
First Online: 17 December 2018
Compliance with ethical standards
:
: B.H.P. has ownership interest and is a paid member of the scientific advisory board of Loxo Oncology and is a paid consultant for Foundation Medicine, Inc, Jackson Labs, Roche, Casdin Capital and H3 Biomedicine. Under separate licensing agreements between Horizon Discovery, LTD and The Johns Hopkins University, B.H.P. is entitled to a share of royalties received by the University on sales of products. The terms of this arrangement are being managed by the Johns Hopkins University in accordance with its conflict of interest policies. No other authors declare potential conflicts of interest.
: All animal experiments were performed in accordance with institutional and The National Institutes of Health Guide for the Care and Use of Laboratory Animals guidelines. All studies were performed in compliance with institutional ethical standards.
: All study participants provided informed consent under an IRB-approved protocol.